The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Diabetes Therapeutics and Diagnostics Market Research Report 2025

Global Diabetes Therapeutics and Diagnostics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1918846

No of Pages : 108

Ask Your Query
Synopsis
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
The global Diabetes Therapeutics and Diagnostics market was valued at US$ 117140 million in 2023 and is anticipated to reach US$ 143500 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diabetes Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Therapeutics and Diagnostics.
Report Scope
The Diabetes Therapeutics and Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetes Therapeutics and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Therapeutics and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
77 Elektronika Kft.
A. Menarini Diagnostics S.R.L
Abbott Laboratories
Agamatrix Inc.
Animas Corp.
Ascensia
Becton Dickinson
Debiotech S.A.
Eli Lilly And Co.
Glaxo Smithkline
Inlight Solutions Inc.
Johnson & Johnson
Lifescan Inc.
Medtronic
Merck & Co.
Merck KGAA
Nipro Corp.
Novartis Pharma Ag
Novo Nordisk A/S
Owen Mumford Ltd.
Palco Labs Inc.
Roche
Sanofi
Takeda Pharmaceutical Co. Ltd.
Terumo Corp.
Segment by Type
Insulin
Insulin Delivery
Oral Hypoglycemic Drugs
Diagnosis And Monitoring
Others
Segment by Application
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Therapeutics and Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Insulin
1.2.3 Insulin Delivery
1.2.4 Oral Hypoglycemic Drugs
1.2.5 Diagnosis And Monitoring
1.2.6 Others
1.3 Market by Application
1.3.1 Global Diabetes Therapeutics and Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.3.4 Gestational Diabetes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Therapeutics and Diagnostics Market Perspective (2019-2030)
2.2 Diabetes Therapeutics and Diagnostics Growth Trends by Region
2.2.1 Global Diabetes Therapeutics and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diabetes Therapeutics and Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Diabetes Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Diabetes Therapeutics and Diagnostics Market Dynamics
2.3.1 Diabetes Therapeutics and Diagnostics Industry Trends
2.3.2 Diabetes Therapeutics and Diagnostics Market Drivers
2.3.3 Diabetes Therapeutics and Diagnostics Market Challenges
2.3.4 Diabetes Therapeutics and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Therapeutics and Diagnostics Players by Revenue
3.1.1 Global Top Diabetes Therapeutics and Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Diabetes Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diabetes Therapeutics and Diagnostics Revenue
3.4 Global Diabetes Therapeutics and Diagnostics Market Concentration Ratio
3.4.1 Global Diabetes Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Therapeutics and Diagnostics Revenue in 2023
3.5 Diabetes Therapeutics and Diagnostics Key Players Head office and Area Served
3.6 Key Players Diabetes Therapeutics and Diagnostics Product Solution and Service
3.7 Date of Enter into Diabetes Therapeutics and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Therapeutics and Diagnostics Breakdown Data by Type
4.1 Global Diabetes Therapeutics and Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030)
5 Diabetes Therapeutics and Diagnostics Breakdown Data by Application
5.1 Global Diabetes Therapeutics and Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diabetes Therapeutics and Diagnostics Market Size (2019-2030)
6.2 North America Diabetes Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024)
6.4 North America Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetes Therapeutics and Diagnostics Market Size (2019-2030)
7.2 Europe Diabetes Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024)
7.4 Europe Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetes Therapeutics and Diagnostics Market Size (2019-2030)
9.2 Latin America Diabetes Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 77 Elektronika Kft.
11.1.1 77 Elektronika Kft. Company Detail
11.1.2 77 Elektronika Kft. Business Overview
11.1.3 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Introduction
11.1.4 77 Elektronika Kft. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.1.5 77 Elektronika Kft. Recent Development
11.2 A. Menarini Diagnostics S.R.L
11.2.1 A. Menarini Diagnostics S.R.L Company Detail
11.2.2 A. Menarini Diagnostics S.R.L Business Overview
11.2.3 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Introduction
11.2.4 A. Menarini Diagnostics S.R.L Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.2.5 A. Menarini Diagnostics S.R.L Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Diabetes Therapeutics and Diagnostics Introduction
11.3.4 Abbott Laboratories Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.3.5 Abbott Laboratories Recent Development
11.4 Agamatrix Inc.
11.4.1 Agamatrix Inc. Company Detail
11.4.2 Agamatrix Inc. Business Overview
11.4.3 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Introduction
11.4.4 Agamatrix Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.4.5 Agamatrix Inc. Recent Development
11.5 Animas Corp.
11.5.1 Animas Corp. Company Detail
11.5.2 Animas Corp. Business Overview
11.5.3 Animas Corp. Diabetes Therapeutics and Diagnostics Introduction
11.5.4 Animas Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.5.5 Animas Corp. Recent Development
11.6 Ascensia
11.6.1 Ascensia Company Detail
11.6.2 Ascensia Business Overview
11.6.3 Ascensia Diabetes Therapeutics and Diagnostics Introduction
11.6.4 Ascensia Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.6.5 Ascensia Recent Development
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Detail
11.7.2 Becton Dickinson Business Overview
11.7.3 Becton Dickinson Diabetes Therapeutics and Diagnostics Introduction
11.7.4 Becton Dickinson Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.7.5 Becton Dickinson Recent Development
11.8 Debiotech S.A.
11.8.1 Debiotech S.A. Company Detail
11.8.2 Debiotech S.A. Business Overview
11.8.3 Debiotech S.A. Diabetes Therapeutics and Diagnostics Introduction
11.8.4 Debiotech S.A. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.8.5 Debiotech S.A. Recent Development
11.9 Eli Lilly And Co.
11.9.1 Eli Lilly And Co. Company Detail
11.9.2 Eli Lilly And Co. Business Overview
11.9.3 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Introduction
11.9.4 Eli Lilly And Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.9.5 Eli Lilly And Co. Recent Development
11.10 Glaxo Smithkline
11.10.1 Glaxo Smithkline Company Detail
11.10.2 Glaxo Smithkline Business Overview
11.10.3 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Introduction
11.10.4 Glaxo Smithkline Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.10.5 Glaxo Smithkline Recent Development
11.11 Inlight Solutions Inc.
11.11.1 Inlight Solutions Inc. Company Detail
11.11.2 Inlight Solutions Inc. Business Overview
11.11.3 Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Introduction
11.11.4 Inlight Solutions Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.11.5 Inlight Solutions Inc. Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Detail
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Diabetes Therapeutics and Diagnostics Introduction
11.12.4 Johnson & Johnson Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.12.5 Johnson & Johnson Recent Development
11.13 Lifescan Inc.
11.13.1 Lifescan Inc. Company Detail
11.13.2 Lifescan Inc. Business Overview
11.13.3 Lifescan Inc. Diabetes Therapeutics and Diagnostics Introduction
11.13.4 Lifescan Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.13.5 Lifescan Inc. Recent Development
11.14 Medtronic
11.14.1 Medtronic Company Detail
11.14.2 Medtronic Business Overview
11.14.3 Medtronic Diabetes Therapeutics and Diagnostics Introduction
11.14.4 Medtronic Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.14.5 Medtronic Recent Development
11.15 Merck & Co.
11.15.1 Merck & Co. Company Detail
11.15.2 Merck & Co. Business Overview
11.15.3 Merck & Co. Diabetes Therapeutics and Diagnostics Introduction
11.15.4 Merck & Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.15.5 Merck & Co. Recent Development
11.16 Merck KGAA
11.16.1 Merck KGAA Company Detail
11.16.2 Merck KGAA Business Overview
11.16.3 Merck KGAA Diabetes Therapeutics and Diagnostics Introduction
11.16.4 Merck KGAA Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.16.5 Merck KGAA Recent Development
11.17 Nipro Corp.
11.17.1 Nipro Corp. Company Detail
11.17.2 Nipro Corp. Business Overview
11.17.3 Nipro Corp. Diabetes Therapeutics and Diagnostics Introduction
11.17.4 Nipro Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.17.5 Nipro Corp. Recent Development
11.18 Novartis Pharma Ag
11.18.1 Novartis Pharma Ag Company Detail
11.18.2 Novartis Pharma Ag Business Overview
11.18.3 Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Introduction
11.18.4 Novartis Pharma Ag Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.18.5 Novartis Pharma Ag Recent Development
11.19 Novo Nordisk A/S
11.19.1 Novo Nordisk A/S Company Detail
11.19.2 Novo Nordisk A/S Business Overview
11.19.3 Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Introduction
11.19.4 Novo Nordisk A/S Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.19.5 Novo Nordisk A/S Recent Development
11.20 Owen Mumford Ltd.
11.20.1 Owen Mumford Ltd. Company Detail
11.20.2 Owen Mumford Ltd. Business Overview
11.20.3 Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Introduction
11.20.4 Owen Mumford Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.20.5 Owen Mumford Ltd. Recent Development
11.21 Palco Labs Inc.
11.21.1 Palco Labs Inc. Company Detail
11.21.2 Palco Labs Inc. Business Overview
11.21.3 Palco Labs Inc. Diabetes Therapeutics and Diagnostics Introduction
11.21.4 Palco Labs Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.21.5 Palco Labs Inc. Recent Development
11.22 Roche
11.22.1 Roche Company Detail
11.22.2 Roche Business Overview
11.22.3 Roche Diabetes Therapeutics and Diagnostics Introduction
11.22.4 Roche Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.22.5 Roche Recent Development
11.23 Sanofi
11.23.1 Sanofi Company Detail
11.23.2 Sanofi Business Overview
11.23.3 Sanofi Diabetes Therapeutics and Diagnostics Introduction
11.23.4 Sanofi Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.23.5 Sanofi Recent Development
11.24 Takeda Pharmaceutical Co. Ltd.
11.24.1 Takeda Pharmaceutical Co. Ltd. Company Detail
11.24.2 Takeda Pharmaceutical Co. Ltd. Business Overview
11.24.3 Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Introduction
11.24.4 Takeda Pharmaceutical Co. Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.24.5 Takeda Pharmaceutical Co. Ltd. Recent Development
11.25 Terumo Corp.
11.25.1 Terumo Corp. Company Detail
11.25.2 Terumo Corp. Business Overview
11.25.3 Terumo Corp. Diabetes Therapeutics and Diagnostics Introduction
11.25.4 Terumo Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024)
11.25.5 Terumo Corp. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Insulin
Table 3. Key Players of Insulin Delivery
Table 4. Key Players of Oral Hypoglycemic Drugs
Table 5. Key Players of Diagnosis And Monitoring
Table 6. Key Players of Others
Table 7. Global Diabetes Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Diabetes Therapeutics and Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Diabetes Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Diabetes Therapeutics and Diagnostics Market Share by Region (2019-2024)
Table 11. Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Diabetes Therapeutics and Diagnostics Market Share by Region (2025-2030)
Table 13. Diabetes Therapeutics and Diagnostics Market Trends
Table 14. Diabetes Therapeutics and Diagnostics Market Drivers
Table 15. Diabetes Therapeutics and Diagnostics Market Challenges
Table 16. Diabetes Therapeutics and Diagnostics Market Restraints
Table 17. Global Diabetes Therapeutics and Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Diabetes Therapeutics and Diagnostics Market Share by Players (2019-2024)
Table 19. Global Top Diabetes Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Therapeutics and Diagnostics as of 2023)
Table 20. Ranking of Global Top Diabetes Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Diabetes Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Diabetes Therapeutics and Diagnostics Product Solution and Service
Table 24. Date of Enter into Diabetes Therapeutics and Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Diabetes Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Type (2019-2024)
Table 28. Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Type (2025-2030)
Table 30. Global Diabetes Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Application (2019-2024)
Table 32. Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Application (2025-2030)
Table 34. North America Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 49. 77 Elektronika Kft. Company Detail
Table 50. 77 Elektronika Kft. Business Overview
Table 51. 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Product
Table 52. 77 Elektronika Kft. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 53. 77 Elektronika Kft. Recent Development
Table 54. A. Menarini Diagnostics S.R.L Company Detail
Table 55. A. Menarini Diagnostics S.R.L Business Overview
Table 56. A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Product
Table 57. A. Menarini Diagnostics S.R.L Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 58. A. Menarini Diagnostics S.R.L Recent Development
Table 59. Abbott Laboratories Company Detail
Table 60. Abbott Laboratories Business Overview
Table 61. Abbott Laboratories Diabetes Therapeutics and Diagnostics Product
Table 62. Abbott Laboratories Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 63. Abbott Laboratories Recent Development
Table 64. Agamatrix Inc. Company Detail
Table 65. Agamatrix Inc. Business Overview
Table 66. Agamatrix Inc. Diabetes Therapeutics and Diagnostics Product
Table 67. Agamatrix Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 68. Agamatrix Inc. Recent Development
Table 69. Animas Corp. Company Detail
Table 70. Animas Corp. Business Overview
Table 71. Animas Corp. Diabetes Therapeutics and Diagnostics Product
Table 72. Animas Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 73. Animas Corp. Recent Development
Table 74. Ascensia Company Detail
Table 75. Ascensia Business Overview
Table 76. Ascensia Diabetes Therapeutics and Diagnostics Product
Table 77. Ascensia Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 78. Ascensia Recent Development
Table 79. Becton Dickinson Company Detail
Table 80. Becton Dickinson Business Overview
Table 81. Becton Dickinson Diabetes Therapeutics and Diagnostics Product
Table 82. Becton Dickinson Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 83. Becton Dickinson Recent Development
Table 84. Debiotech S.A. Company Detail
Table 85. Debiotech S.A. Business Overview
Table 86. Debiotech S.A. Diabetes Therapeutics and Diagnostics Product
Table 87. Debiotech S.A. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 88. Debiotech S.A. Recent Development
Table 89. Eli Lilly And Co. Company Detail
Table 90. Eli Lilly And Co. Business Overview
Table 91. Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Product
Table 92. Eli Lilly And Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 93. Eli Lilly And Co. Recent Development
Table 94. Glaxo Smithkline Company Detail
Table 95. Glaxo Smithkline Business Overview
Table 96. Glaxo Smithkline Diabetes Therapeutics and Diagnostics Product
Table 97. Glaxo Smithkline Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 98. Glaxo Smithkline Recent Development
Table 99. Inlight Solutions Inc. Company Detail
Table 100. Inlight Solutions Inc. Business Overview
Table 101. Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Product
Table 102. Inlight Solutions Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 103. Inlight Solutions Inc. Recent Development
Table 104. Johnson & Johnson Company Detail
Table 105. Johnson & Johnson Business Overview
Table 106. Johnson & Johnson Diabetes Therapeutics and Diagnostics Product
Table 107. Johnson & Johnson Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 108. Johnson & Johnson Recent Development
Table 109. Lifescan Inc. Company Detail
Table 110. Lifescan Inc. Business Overview
Table 111. Lifescan Inc. Diabetes Therapeutics and Diagnostics Product
Table 112. Lifescan Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 113. Lifescan Inc. Recent Development
Table 114. Medtronic Company Detail
Table 115. Medtronic Business Overview
Table 116. Medtronic Diabetes Therapeutics and Diagnostics Product
Table 117. Medtronic Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 118. Medtronic Recent Development
Table 119. Merck & Co. Company Detail
Table 120. Merck & Co. Business Overview
Table 121. Merck & Co. Diabetes Therapeutics and Diagnostics Product
Table 122. Merck & Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 123. Merck & Co. Recent Development
Table 124. Merck KGAA Company Detail
Table 125. Merck KGAA Business Overview
Table 126. Merck KGAA Diabetes Therapeutics and Diagnostics Product
Table 127. Merck KGAA Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 128. Merck KGAA Recent Development
Table 129. Nipro Corp. Company Detail
Table 130. Nipro Corp. Business Overview
Table 131. Nipro Corp. Diabetes Therapeutics and Diagnostics Product
Table 132. Nipro Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 133. Nipro Corp. Recent Development
Table 134. Novartis Pharma Ag Company Detail
Table 135. Novartis Pharma Ag Business Overview
Table 136. Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Product
Table 137. Novartis Pharma Ag Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 138. Novartis Pharma Ag Recent Development
Table 139. Novo Nordisk A/S Company Detail
Table 140. Novo Nordisk A/S Business Overview
Table 141. Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Product
Table 142. Novo Nordisk A/S Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 143. Novo Nordisk A/S Recent Development
Table 144. Owen Mumford Ltd. Company Detail
Table 145. Owen Mumford Ltd. Business Overview
Table 146. Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Product
Table 147. Owen Mumford Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 148. Owen Mumford Ltd. Recent Development
Table 149. Palco Labs Inc. Company Detail
Table 150. Palco Labs Inc. Business Overview
Table 151. Palco Labs Inc. Diabetes Therapeutics and Diagnostics Product
Table 152. Palco Labs Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 153. Palco Labs Inc. Recent Development
Table 154. Roche Company Detail
Table 155. Roche Business Overview
Table 156. Roche Diabetes Therapeutics and Diagnostics Product
Table 157. Roche Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 158. Roche Recent Development
Table 159. Sanofi Company Detail
Table 160. Sanofi Business Overview
Table 161. Sanofi Diabetes Therapeutics and Diagnostics Product
Table 162. Sanofi Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 163. Sanofi Recent Development
Table 164. Takeda Pharmaceutical Co. Ltd. Company Detail
Table 165. Takeda Pharmaceutical Co. Ltd. Business Overview
Table 166. Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Product
Table 167. Takeda Pharmaceutical Co. Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 168. Takeda Pharmaceutical Co. Ltd. Recent Development
Table 169. Terumo Corp. Company Detail
Table 170. Terumo Corp. Business Overview
Table 171. Terumo Corp. Diabetes Therapeutics and Diagnostics Product
Table 172. Terumo Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
Table 173. Terumo Corp. Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Therapeutics and Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Diabetes Therapeutics and Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Insulin Features
Figure 4. Insulin Delivery Features
Figure 5. Oral Hypoglycemic Drugs Features
Figure 6. Diagnosis And Monitoring Features
Figure 7. Others Features
Figure 8. Global Diabetes Therapeutics and Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Diabetes Therapeutics and Diagnostics Market Share by Application: 2023 VS 2030
Figure 10. Type 1 Diabetes Case Studies
Figure 11. Type 2 Diabetes Case Studies
Figure 12. Gestational Diabetes Case Studies
Figure 13. Others Case Studies
Figure 14. Diabetes Therapeutics and Diagnostics Report Years Considered
Figure 15. Global Diabetes Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Diabetes Therapeutics and Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Diabetes Therapeutics and Diagnostics Market Share by Region: 2023 VS 2030
Figure 18. Global Diabetes Therapeutics and Diagnostics Market Share by Players in 2023
Figure 19. Global Top Diabetes Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Therapeutics and Diagnostics as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Diabetes Therapeutics and Diagnostics Revenue in 2023
Figure 21. North America Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Diabetes Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 23. United States Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Diabetes Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 27. Germany Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Share by Region (2019-2030)
Figure 35. China Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Diabetes Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 43. Mexico Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Share by Country (2019-2030)
Figure 47. Turkey Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. 77 Elektronika Kft. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 50. A. Menarini Diagnostics S.R.L Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 51. Abbott Laboratories Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 52. Agamatrix Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 53. Animas Corp. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 54. Ascensia Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 55. Becton Dickinson Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 56. Debiotech S.A. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 57. Eli Lilly And Co. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 58. Glaxo Smithkline Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 59. Inlight Solutions Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 60. Johnson & Johnson Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 61. Lifescan Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 62. Medtronic Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 63. Merck & Co. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 64. Merck KGAA Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 65. Nipro Corp. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 66. Novartis Pharma Ag Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 67. Novo Nordisk A/S Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 68. Owen Mumford Ltd. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 69. Palco Labs Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 70. Roche Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 71. Sanofi Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 72. Takeda Pharmaceutical Co. Ltd. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 73. Terumo Corp. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2019-2024)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock